FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| "Eagle Pharmacy, Inc.(038598540)" | 69852-123 | 69852-123-10 | Ketorolac Tromethamine | 30 mg/30 mg | 2021-2 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9131 | 51754-9131-5 | Midazolam Hydrochloride | 100 mg/100 mL | 2021-2 | valid | 2026-11-12 | ||
| "Exela Pharma Sciences, LLC.(831274399)" | 51754-9160 | 51754-9160-1 | Fentanyl Citrate | 5000 ug/100 mL | 2021-2 | valid | 2026-11-12 | ||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | .8 mg/.8 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride | 4 mg/.8 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Bromfenac Sodium | 5 mg/1 mL; .75 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Moxifloxacin Hydrochloride; Dexamethasone Sodium Phosphate | 5 mg/1 mL; 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate | 1 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Nepafenac; Prednisolone Acetate; Moxifloxacin Hydrochloride | 1 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ondansetron Hydrochloride; Ketamine Hydrochloride; Midazolam | 2 mg/.165 g; 25 mg/.165 g; 3 mg/.165 g | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide | 25 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Phenylephrine Hydrochloride; Tropicamide; Proparacaine Hydrochloride; Ketorolac Tromethamine | 25 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Prednisolone Acetate; Moxifloxacin Hydrochloride | 10 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate | .75 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Bromfenac Sodium; Prednisolone Acetate; Moxifloxacin Hydrochloride | .75 mg/1 mL; 10 mg/1 mL; 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Triamcinolone Acetonide; Moxifloxacin Hydrochloride | 15 mg/1 mL; 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Cyclosporine | 1 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Dexamethasone Sodium Phosphate; Moxifloxacin Hydrochloride; Ketorolac Tromethamine | 1 mg/1 mL; .5 mg/1 mL; .4 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Lidocaine Hydrochloride; Epinephrine Hydrochloride | 7.5 mg/1 mL; .25 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "Imprimis NJOF, LLC(080431967)" | Ascorbic Acid | 500 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0012 | 71139-0012-1 | Oxytocin | 30 U/500 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7084 | 71139-7084-1 | Phenylephrine Hydrochloride | 1 mg/10 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6564 | 71139-6564-1 | Succinylcholine Chloride | 100 mg/5 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7153 | 71139-7153-1 | Cefazolin Sodium | 3 g/123 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-7087 | 71139-7087-1 | Cefazolin Sodium | 2 g/20 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0190 | 71139-0190-1 | "vasopressin, Unspecified" | 2 U/2 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6643 | 71139-6643-1 | Ephedrine Sulfate | 25 mg/5 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-6030 | 71139-6030-1 | Fentanyl Citrate | 2500 ug/50 mL | 2021-2 | valid | 2026-11-12 | ||
| "IntegraDose Compounding Services, LLC(080467666)" | 71139-0018 | 71139-0018-1 | Hydromorphone Hydrochloride | 20 mg/100 mL | 2021-2 | valid | 2026-11-12 | ||
| "KRS Global Biotechnology, Inc.(014763459)" | Moxifloxacin | .6 mg/.6 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 16000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 32000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 32000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Norepinephrine | 64000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | .4 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride | 1 mg/10 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Phenylephrine Hydrochloride; Lidocaine Hydrochloride | 15 mg/1 mL; 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Rocuronium Bromide | 10 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Succinylcholine Chloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Succinylcholine Chloride | 20 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Ephedrine Sulfate | 5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Ephedrine; Lidocaine Hydrochloride | .25 mg/1 mL; 7.5 mg/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Fentanyl Citrate | 25000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 | ||||
| "KRS Global Biotechnology, Inc.(014763459)" | Fentanyl Citrate | 25000 ng/1 mL | 2021-2 | source_no_ndc | 2026-11-12 |